Clinical Trials Directory

Trials / Unknown

UnknownNCT05581628

FREQUENCY OF FIBROMYALGIA IN PATIENTS WITH CELIAC DISEASE

EVALUATION OF THE FREQUENCY OF FIBROMYALGIA IN PATIENTS WITH CELIAC DISEASE

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Bezmialem Vakif University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

950 / 5.000 Çeviri sonuçları Celiac disease is an autoimmune proximal small bowel disease that develops as a persistent intolerance to gluten-like gluten in cereals, mainly wheat gluten and other cereal proteins such as barley, rye, and oats in genetically susceptible individuals. Fibromyalgia syndrome (FMS) is a chronic musculoskeletal disease characterized by chronic widespread body pain, fatigue, morning stiffness, subjective swelling, sleep disturbance, intestinal problems, multiple somatic and cognitive problems, especially in the back, neck, shoulders and hips. In terms of intestinal symptoms, very similar findings can be observed between celiac disease and fibromyalgia. For this reason, the presence of celiac disease in FMS patients has been investigated in many studies and its frequency has been found to be high. However, the frequency of FMS in patients with celiac disease is not clear, and an overlooked diagnosis of fibromyalgia may leave many symptoms untreated.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPain location inventory (PLI)PLI is obtained by questioning the pain in 28 regions in the last 7 days. Total score is between 0-28
DIAGNOSTIC_TESTSymptom Impact Questionnaire (SIQR)The SIQR score includes a total of 10 different evaluations in the last 7 days, including pain, energy, stiffness, sleep, depression, memory problems, anxiety, sensitivity to touch, balance problems, sensitivity to loud sounds-bright light-smells-cold. Each item is scored between 0-10 and the total score is obtained between 0-100. This total score is divided by 2 to get the SIQR score
DIAGNOSTIC_TESTFibromyalgia Impact Questionnaire (FIQ)FIQ measures 10 different features, including physical function, well-being, absenteeism, difficulty at work, pain, fatigue, morning fatigue, stiffness, anxiety and depression. With the exception of the well-being trait, low scores indicate recovery or less affliction. The maximum possible score of each sub-title is 10. Thus, the total maximum score is 100.

Timeline

Start date
2022-09-28
Primary completion
2022-12-28
Completion
2022-12-28
First posted
2022-10-14
Last updated
2022-10-14

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05581628. Inclusion in this directory is not an endorsement.